State of Kentucky Presents Danimer Scientific With Honorary Proclamation on National Biobased Products Day
Danimer Scientific, Inc. (NYSE: DNMR) has been recognized by the state of Kentucky for its innovative contributions to the biobased products industry during National Biobased Products Day on March 8. Katie Smith from the Kentucky Cabinet for Economic Development presented the proclamation at Danimer's Winchester facility, highlighting the company's commitment to sustainable bioplastics. The Winchester site is noted as the world's first commercial production facility for FDA-approved Nodax®, a fully biodegradable material suitable for food contact applications. Danimer's bioplastics are already utilized in popular U.S. chains like Starbucks and Costco.
- Recognition from Kentucky for innovative biobased product initiatives.
- First commercial production facility for FDA-approved biodegradable Nodax®.
- Products already adopted by major retailers, enhancing market presence.
- None.
State and local dignitaries visit bioplastics manufacturer’s
National Biobased Products Day, established in 2023 by the
“We appreciate Gov.
The guests also toured Danimer’s facility, learning more about the company’s products and capabilities.
"I enjoyed my visit to Danimer’s facility and found it extremely interesting to learn more about the innovations they’re making in the bioplastics industry,”
Danimer’s
Among other places, Danimer’s PHA formulations can currently be found in all
For more information, please visit www.DanimerScientific.com.
About
Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations. For more information, visit www.DanimerScientific.com.
Forward‐Looking Statements
Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company’s exposure to product liability or product warranty claims and other loss contingencies; disruptions and other impacts to the Company’s business, as a result of the COVID-19 global pandemic and government actions and restrictive measures implemented in response; stability of the Company’s manufacturing facilities and suppliers, as well as consumer demand for our products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact on our business, operations and financial results from the ongoing conflict in
View source version on businesswire.com: https://www.businesswire.com/news/home/20230313005208/en/
For Danimer:
Investors
ir@danimer.com
Phone: 229-220-1103
Media
jhoughton@daltonagency.com
Phone: 615-515-4892
Source:
FAQ
What recognition did Danimer Scientific (DNMR) receive in March 2023?
Where is Danimer Scientific's production facility located?
What is Nodax® and why is it significant for Danimer Scientific?